Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia

Dartmouth Health

Status: Withdrawn

Conditions: Chronic Lymphocytic Leukemia

Treatments: Other: No Intervention

Study type: Observational

Funder types: Other

Identifiers

NCT01069432

D1019

Details and patient eligibility

About

The purpose of this study is to collect a blood sample from patients with Chronic Lymphocytic Leukemia (CLL) and from volunteers without CLL.

Full description

The blood sample will be used in the laboratory to perform focused studies on Chronic Lymphocytic Leukemia (CLL).

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing routine blood draws as part of their ongoing follow-up care for CLL at the Norris Cotton Cancer Center of DHMC.
• Normal donors who have no history of active or prior hematologic malignancy.

Exclusion criteria

• Patients who have received cytotoxic drug, oral or intravenous steroid or targeted antibody therapy for their CLL, other hematologic malignancy or other disease process within the past 2 months are excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.
• Normal donors who have a history of steroid use, immunosuppression therapy or autoimmune disease are excluded.

Trial design

0 participants in 2 patient groups

Patients with CLL

Description:

Patients undergoing routine blood draws as part of their ongoing follow-up care for CLL at the Norris Cotton Cancer Center of DHMC.

Treatment:

Other: No Intervention

Normal Volunteers

Description:

Normal volunteers who have no history of active or prior hematologic malignancy.

Treatment:

Other: No Intervention